Israel’s Genetika+ is developing a precision tool to determine if a particular antidepressant will work for an individual. It will also apparently highlight any side effects. (See also Taliaz.) https://nocamels.com/2022/09/brain-in-a-dish-tech-antidepressant/ https://www.genetikaplus.com/ https://www.youtube.com/watch?v=7oovQR2j1M8

Israel’s Taliaz (reported here previously) has just received a $2.7 million grant from the European Union’s Horizon 2020 program. It will help Taliaz expand its clinical research using its PREDICTIX products to help psychiatrists treat and manage patient depression in … Continue reading →

Israel’s Taliaz is partnering with Psychiatry UK to deliver artificial intelligence-driven genetic testing to depression sufferers. Their Predictix service aims to reduce patient suffering by helping psychiatrists better identify the right antidepressant medication earlier. https://www.israel21c.org/artificial-intel-finds-best-antidepressant-for-a-patient/ https://www.psychiatry-uk.com/predictix-genetic-testing/ https://www.taliazhealth.com/